Beta-Pro is a Biotechnology, Cellular Services Company for Diabetes Research
The mission of Beta-Pro is to facilitate a cure for diabetes by establishing a sustainable source
and distribution network of customized in vitro cellular services for use in regenerative
medicine and cell replacement therapies.
Beta-Pro accomplishes this
mission
by:
- Expanding knowledge of human islet cell biology
- Harvesting donor organs that are not suitable for transplantation
- Providing in vitro islet
cell cultures for biomedical research
- Developing technologies to preserve islet
cells post-transplant
- Improving islet cell processing techniques
- Improving islet
cell culture and expansion
- Improving non-invasive cellular imaging in vivo
- Developing
new sources of insulin-producing, glucose-responsive cells
Cellular Services and Cellular Therapy Offer Hope for Regenerative Medicine
We believe cellular therapy now offers people with diabetes and other medical conditions
a chance to reverse disease. That is why university research laboratories, contract
research corporations, pharmaceutical companies, and medical institutions with cellular
transplant programs are interested in our custom islet cells and in vitro cellular services.
|